Monocyte count a potential biomarker for IPF prognosis, Australian registry data show

Routinely measured blood cell tests could be used to stratify  IPF patients by risk for poor outcomes and lung transplantation allocation, Australian research suggests. Increased monocyte count is a predictor of survival in patients with idiopathic pulmonary fibrosis, an analysis of data from the Australian IPF registry has shown. Respiratory physicians have confirmed US results ...

Already a member?

Login to keep reading.

© 2022 the limbic